BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24706711)

  • 1. A dysmorphic newborn with petechiae and a 'Big Heart'.
    Oh LZ; Ng PM; Quah TC
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24706711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient myeloproliferative disorder and eosinophilic pericardial effusion in a down syndrome neonate.
    Shenoy RD; Bhat KG; Kamath N; Kumble Y
    Pediatr Hematol Oncol; 2008 Mar; 25(2):123-9. PubMed ID: 18363179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct clones are associated with the development of transient myeloproliferative disorder and acute megakaryocytic leukemia in a patient with Down syndrome.
    Kanegane H; Watanabe S; Nomura K; Xu G; Ito E; Miyawaki T
    Int J Hematol; 2007 Oct; 86(3):250-2. PubMed ID: 17988992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor in transient myeloproliferative disorder of Down syndrome.
    Hirono K; Miura M; Kanegane H; Miyamoto M; Yoshimura N; Ichida F; Ito E; Miyawaki T
    Pediatr Int; 2009 Oct; 51(5):754-5. PubMed ID: 19799747
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute megakaryoblastic leukemia in Down syndrome.
    Hitzler JK
    Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1066-9. PubMed ID: 17943965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute leukemias in children with Down syndrome.
    Seewald L; Taub JW; Maloney KW; McCabe ER
    Mol Genet Metab; 2012 Sep; 107(1-2):25-30. PubMed ID: 22867885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without Down syndrome.
    Brissette MD; Duval-Arnould BJ; Gordon BG; Cotelingam JD
    Am J Hematol; 1994 Dec; 47(4):316-9. PubMed ID: 7977305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A newborn with Down syndrome-transient myeloproliferative disorder.
    Akdag A; Tunç B; Oğuz S; Dilli D; Dilmen U
    J Perinat Med; 2010 Jul; 38(4):445-7. PubMed ID: 20443668
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder.
    Xu G; Kato K; Toki T; Takahashi Y; Terui K; Ito E
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):696-8. PubMed ID: 17023834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient leukemia-associated pericardial tamponade in a neonate with Down syndrome.
    Buyukkale G; Cetinkaya M; Akcay A; Payaslı M; Oztarhan K; Ozbek AS; Kavuncuoglu S
    Pediatr Hematol Oncol; 2012 May; 29(4):386-8. PubMed ID: 22568804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient myeloproliferative disorder in Down's syndrome: three cases with megakaryocytic markers.
    Sartori PC; Darbyshire PJ
    Pediatr Hematol Oncol; 1991; 8(2):139-45. PubMed ID: 1830754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome.
    Ito E; Kasai M; Hayashi Y; Toki T; Arai K; Yokoyama S; Kato K; Tachibana N; Yamamoto M; Yokoyama M
    Br J Haematol; 1995 Jul; 90(3):607-14. PubMed ID: 7647001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megakaryoblastic leukaemia in Down's syndrome.
    Eguchi M; Sakaibara H; Suda J; Ozawa T; Hayashi Y; Sato T; Kojima S; Furukawa T
    Br J Haematol; 1989 Nov; 73(3):315-22. PubMed ID: 2532535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinatal visceral fibrosis accompanying the megakaryoblastic leukemoid reaction of Down syndrome.
    Becroft DM; Zwi LJ
    Pediatr Pathol; 1990; 10(3):397-406. PubMed ID: 2140891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine diagnosis and management of transient myeloproliferative disorder.
    Strobelt N; Ghidini A; Locatelli A; Vergani P; Mariani S; Biondi A
    Am J Perinatol; 1995 Mar; 12(2):132-4. PubMed ID: 7779196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient myeloproliferative disorder.
    Moiz B; Shafiq M
    Blood; 2012 Dec; 120(24):4672. PubMed ID: 23350067
    [No Abstract]   [Full Text] [Related]  

  • 17. Fetal origin of the GATA1 mutation in identical twins with transient myeloproliferative disorder and acute megakaryoblastic leukemia accompanying Down syndrome.
    Shimada A; Xu G; Toki T; Kimura H; Hayashi Y; Ito E
    Blood; 2004 Jan; 103(1):366. PubMed ID: 14684662
    [No Abstract]   [Full Text] [Related]  

  • 18. Transient myeloproliferative disorder with 11q23 aberration in two neonates with Down syndrome.
    Granzen B; Bernhard B; Reinisch I; Skopnik H; Mertens R
    Ann Hematol; 1998; 77(1-2):51-4. PubMed ID: 9760153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis.
    Mundschau G; Gurbuxani S; Gamis AS; Greene ME; Arceci RJ; Crispino JD
    Blood; 2003 Jun; 101(11):4298-300. PubMed ID: 12560215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of trisomy 21 on early human hematopoiesis.
    Roy A; Cowan G; Vyas P; Roberts I
    Cell Cycle; 2013 Feb; 12(4):533-4. PubMed ID: 23343767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.